Edgar
Lookup
Industries
Insiders
Forms
Rankings
Articles
Home
/
Summit Therapeutics Inc.
/
Filings
/
6-K
6-K
6-K
Company
Summit Therapeutics Inc.
Filed
May 3, 2018
Period of Report
May 3, 2018
Accession Number
0001193125-18-150862
View Document ↗
View on SEC.gov ↗